Comprehensive Resistance Prediction for Tuberculosis:
an International Consortium
Home
Partners
Public Engagement
News
Publications
Contacts
Institutions
Philip Fowler
2021-09-15T15:06:42+01:00
Asia
The Foundation for Medical Research, Mumbai, India
Hinduja Hospital, Mumbai, India
Chinese Center for Disease Control and Prevention, Beijing, China
Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam
National University of Singapore, Singapore
University of New South Wales, Sydney, Australia
National TB Reference Laboratory, National TB Control Program, Islamabad, Pakistan
Taiwan Centers for Disease Control, Taipei, Taiwan
Royal Centre for Disease Control, Department of Public Health, Thimphu, Bhutan
Tropical Diseases Foundation, Manila, Philippines
Africa
National Institute for Communicable Diseases, Johannesburg, South Africa
University of Cape Town, Cape Town, South Africa
Africa Health Research Institute, Durban, South Africa
Stellenbosch University, Cape Town, South Africa
Wellcome Centre for Infectious Diseases Research in Africa, Cape Town, South Africa
Institut Pasteur de Madagascar, Antananarivo, Madagascar
Europe
Modernising Medical Microbiology, Nuffield Department of Medicine, University of Oxford, Oxford, UK
EMBL’s European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK
San Raffaele Scientific Institute, Milan, Italy
Vita-Salute San Raffaele University, Milan, Italy
Research Center Borstel, Borstel, Germany
SYNLAB Gauting, Munich, Germany
Institute of Microbiology and Laboratory Medicine, IMLred, WHO-SRL Gauting, Germany
Institut Pasteur de Lille, Lille, France
Public Health Agency of Sweden, Solna, Sweden
University of Antwerp, Antwerp, Belgium
Scottish Mycobacteria Reference Laboratory, Edinburgh, UK
University of Edinburgh, Edinburgh, UK
UK Health Security Agency, London, UK
Public Health England, UK
London School of Hygiene and Tropical Medicine, London, UK
Imperial College, London, UK
World Health Organisation, The Global TB Programme
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
North America
Yale School of Public Health, Yale, USA
Wadsworth Center, New York State Department of Health, Albany, USA
University of California, San Diego, USA
British Columbia Centre for Disease Control, Vancouver, Canada
Bill & Melinda Gates Foundation, Seattle, USA
Public Health Ontario, Toronto, Canada
Université ́de Montréal, Canada
USA Centre for Disease Control and Prevention, Atlanta, USA
Janssen Therapeutics, New Jersey, USA
Critical Path to TB Drug Regimens (CPTR), Arizona, USA
Icahn School of Medicine at Mount Sinai, New York City, USA
Relational Sequencing TB Data Platform (ReSeqTB)
South America
Institute Adolfo Lutz, Sa ̃o Paulo, Brazil
Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Universidad Peruana Cayetano Heredia, Lima, Perú
Instituto Nacional de Salud, Lima, Perú
